Literature DB >> 22782443

Stabilisation of cardiopulmonary function in newborns with congenital diaphragmatic hernia using lung function parameters and hemodynamic management.

S R Hofmann1, K Stadler, A Heilmann, H J Häusler, G Fitze, G Kamin, K I Nitzsche, G Hahn, J Dinger.   

Abstract

OBJECTIVE: Evaluation of lung function parameters and additional use of prostaglandin E1 (PGE1) for the stabilisation of cardiopulmonary function in patients with congenital diaphragmatic hernia (CDH) and pulmonary hypertension (PHT).
DESIGN: Observational study. PATIENTS: Between 2007 and 2009 8 patients with CDH have been treated in our pediatric intensive care unit (gestational age 34 + 0 - 40 + 4 weeks, birth weight 2 160-3 840 g). All patients required respiratory support. Gentle mechanical ventilation adapted to the degree of pulmonary hypoplasia based on serially measurements of lung function parameters to find appropriate ventilator settings has been performed. MAIN
RESULTS: Functional residual capacity (FRC) and compliance of the respiratory system in all patients were markedly reduced. A FRC between 9.3-10.6 ml/kg and compliance between 1.1-1.8 ml/kPa/kg indicated pronounced hypoplasia of the lungs. Doppler flow patterns through the arterial duct were classified into left-to-right, right-to-left and bidirectional shunting and correlated to the degree of PHT. The additional use of PGE1 to reopen the arterial duct and to stabilize right ventricular function led to an amelioration of severe PHT and preoperative stabilisation in 2 newborns with pronounced pulmonary hypoplasia. All patients underwent successful surgery, and did not show any complications after 2 years follow-up.
CONCLUSION: Measurements of lung function parameters and adaptation of mechanical ventilation to the degree of pulmonary hypoplasia and additional therapy with PGE1 may help to improve the outcome in CDH patients. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22782443     DOI: 10.1055/s-0031-1299731

Source DB:  PubMed          Journal:  Klin Padiatr        ISSN: 0300-8630            Impact factor:   1.349


  6 in total

Review 1.  Use of Prostaglandin E1 in the Management of Congenital Diaphragmatic Hernia-A Review.

Authors:  Srirupa Hari Gopal; Neil Patel; Caraciolo J Fernandes
Journal:  Front Pediatr       Date:  2022-07-01       Impact factor: 3.569

Review 2.  Congenital diaphragmatic hernia, management in the newborn.

Authors:  Merrill McHoney
Journal:  Pediatr Surg Int       Date:  2015-09-24       Impact factor: 1.827

3.  Long-term maturation of congenital diaphragmatic hernia treatment results: toward development of a severity-specific treatment algorithm.

Authors:  David W Kays; Saleem Islam; Shawn D Larson; Joy Perkins; James L Talbert
Journal:  Ann Surg       Date:  2013-10       Impact factor: 12.969

4.  Management Practice and Mortality for Infants with Congenital Diaphragmatic Hernia.

Authors:  Jonathan R Malowitz; Christoph P Hornik; Matthew M Laughon; Daniela Testoni; C Michael Cotten; Reese H Clark; P Brian Smith
Journal:  Am J Perinatol       Date:  2015-02-25       Impact factor: 3.079

5.  Tissue Engineering to Repair Diaphragmatic Defect in a Rat Model.

Authors:  G P Liao; Y Choi; K Vojnits; H Xue; K Aroom; F Meng; H Y Pan; R A Hetz; C J Corkins; T G Hughes; F Triolo; A Johnson; Kenneth J Moise; K P Lally; C S Cox; Y Li
Journal:  Stem Cells Int       Date:  2017-08-27       Impact factor: 5.443

Review 6.  Developmental Pathways Underlying Lung Development and Congenital Lung Disorders.

Authors:  Inês Caldeira; Hugo Fernandes-Silva; Daniela Machado-Costa; Jorge Correia-Pinto; Rute Silva Moura
Journal:  Cells       Date:  2021-11-02       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.